on BASTIDE (EPA:BLC)
The Bastide Group sells EXPERF to Sapio Group
The Bastide Group has reached an agreement to sell its subsidiary New Medical Concept, the holding company of EXPERF, to Sapio Group. Specializing in home infusion and nutrition, EXPERF has doubled its revenue since its acquisition by Bastide in 2017.
Revenue increased from €18 million to €42 million for the 2024-2025 financial year. This sale is part of the Bastide Group's debt reduction strategy, allowing it to improve its financial leverage ratio after the transaction, which is expected to have no impact on 2026 revenue.
Sapio, leveraging EXPERF's network in France, aims to strengthen its position in Europe. The completion of the transaction remains subject to customary closing conditions.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news